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Introduction: About 20% of febrile neutropenic patients are presented with bloodstream infection which is a
leading cause of mortality among these patients. Awareness of the locally prevalent pathogens and their sus-
ceptibility pattern is important for proper treatment of infection which improves survival in these patients. The
objective of this study was to determine the frequency of bloodstream infection in patients with febrile neu-
tropenia admitted in Abbasi Shaheed Hospital.
Methods: This cross-sectional study was conducted in the Medical wards in Abbasi Shaheed Hospital, Karachi
from 21-2-2016 to 20-8-2017. Patients of over 15 years of age of either gender with severe neutropenia were
included in this study. Patients with noninfectious cause of fever, or fever prior to neutropenia were excluded.
Patients meeting inclusion criteria were enrolled after taking informed consent. About 2–5ml blood was col-
lected under aseptic measures in Bactac culture bottles. Blood samples were sent to lab within 30min of col-
lection. Antimicrobial sensitivity testing of all isolates was performed on diagnostic Sensitivity test plates by
Kerby – Bauer Method. Patients were referred back to treating physician if blood culture is positive. The data was
analyzed using SPSS version 20.
Results: Of 200 patients, the mean age was 25.8 ± 5.7 years, 120 (60%) were male with male to female ratio of
1.5:1, 89 (44.5%) had low grade fever (Temp.≤102 °C) and 111 (55.5%) had high grade fever(Temp.> 102 °C).
The frequency of staphylococcus aureus was 16%, E. coli was 14.5%, Pseudomonas 8.5% and Klebsiella 15.5%
Conclusions: It is concluded that the frequency of staphylococcus aureus was 16%, E. coli was 14.5%, Pseudomonas
8.5% and Klebsiella 15.5%
1. Introduction
Patients with febrile neutropeniaare more susceptible to life threa-
tening bacterial infections due to lack of inflammatory response [1].
Hence, febrile neutropenia should be dealt as an emergency and ad-
ministration of empirical antibiotics may improve survival in these
patients [2].According to American college of physicians and society of
critical care medicine which include axillary temperature> 38C, heart
rate> 90/mainland respiratory rate> 20/min. Absolute neutrophic
count is 500/mm3 The reported risk of bloodstream infection in pa-
tients with febrile neutropenia is between 11 and 38% [3].
Staphylococcus aureus was the most common isolate among the
Gram-positive organisms (53%), while Pseudomonas aeruginosa,
Escherichia coli, and Klebsiella pneumoniae were the 3 leading Gram-
negative isolates (42%) [4].Mortality rate due to gram-negative pa-
thogens was 18% and gram-positive pathogen was 5% [5,6].
Compared to previous reports, the pattern of bacterial isolates and
their resistance to antibiotics has changed over the past years. Gram-
positive organisms predominated in the 50s and 60s, gram negative
later, the emergence of multi-drug resistant aerobic rods in 90s and a
shift back to gram positive in last two decades in some regions has
created problems of effective therapy [7,8].
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Management of patients with febrile neutropenic is complex and
involves careful consideration of multiple factorslike primary under-
lying etiology, duration, and severity of the neutropenia, Improved
broad-spectrum antibiotic agents, combined with improved supportive
care, have improved the prognosis for most patients with severe neu-
tropenia. A study showed more than 30 years ago that there was an
inverse relationship between the absolute neutrophil count and life
threatening infections [9,10].A delay of more than 48 h in the admin-
istration of appropriate antibiotics may result in a mortality rate of
approximately 50% [10].
Identification of the locally prevalent pathogens and their suscept-
ibility pattern is important, before putting neutropenic patients on
empiric antimicrobial regimens, Bacterial infections are the major cause
of morbidity and mortality among neutropenic patients. Thus, the ob-
jective of the study was to determine the frequency of bloodstream
infection responsible for blood stream infection (BSI) in febrile neu-
tropenic patients admitted in xxxxxx Hospital so that appropriate an-
tibiotic therapy should be started to reduce mortality.
2. Material and methods
This cross sectional study was conducted in Department of
Medicine, xxxxxxxx Hospital from 21-February-2016 to 20-August-
2017. Department of Medicine is a 120 bedded medical unit admitting
approximately X patients per day.
Patients of age over 15 years with moderate to severe neutropenia
due to infection (viral, bacterial, protozoal and fungal) or immune
neutropanias or hypersplenism or hematological and non-hematolo-
gical malignancies or vitamin B12, folate deficiency or radiation or
chemotherapy or hemodialysis were included in this study. Patients of
age< 15 years developing fever due to noninfectious causes as after
6–24 h of transfusion of blood products or drug infusion or had fever
prior to neutropenia or those who did not give written consent were
excluded from the study. Patients from medical unit were selected after
the approval of the ethical board review committee of hospital and
College of Physicians and Surgeons. Patients who fulfilled inclusion
criteria were enrolled in the study after taking informed consent. The
data were collected from all neutropenic patients (defined as, an ab-
solute neutrophil count (ANC) of less than 1500/ml and running
fever).Fever was defined as a single oral temperature≥38.3 °C (101 °F)
for atleast 1 h or a temperature of ≥38 °C or 100.4 °F on two or more
occasions within 12-24-hourperiod. Four to five ml of venous blood was
taken under aseptic technique and is collected in a Bactec blood cul-
tures bottle. Blood culture was sent to laboratory within 20min of
collection. Antimicrobial sensitivity testing of all isolates was per-
formed on diagnostic sensitivity test plates by Kerby – Bauer Method;
Staphylococcus aureus was identified as round grape like colonies under
microscopy; Pseudomonas aeruginosa, as rod shaped bacteria with uni-
polar motility; E. coli, as rod shaped, 2mm long and 0.5 μm in diameter
and Klebsiella pneumonae was identified as small rod shaped structures
inoculated in MacConkey culture. Data were recorded in a structured
questionnaire. Patients were referred back to treating physician if blood
culture is positive for further assessment and treatment.
The sample size of 200 was calculated assuming prevalence of
neutropenia of 7.2%, bond on error of estimation of 4% and confidence
level of 95%. Data analysis was performed through SPSS Version-20.
Mean and SD was calculated for age, and temperature. Frequency and
percentages was calculated for various bacterial agents which were
staphylococcus aureus, E.coli, Pseudomonas aeruginosaand Klebsiella
pneumonae. Stratification was done based on age and gender to see
effect on outcome variable through Chi-square test and p-value
of< 0.05 was considered significant.
3. Results
A total of 200 patients were enrolled in this study. Mean age was
25.8 ± 5.7 years, 120 (60%) were male with male to female ratio of
1.5:1, 89 (44.5%) had low grade fever (Temp. 102 C) and 111 (55.5%)
had high grade fever.The frequency of Staphylococcus aureus was 16%,
E. coli was 14.5%, Pseudomonas aeruginosa 8.5% and Klebsiella pneu-
monae was 15.5% (Table 1) (see Table 2 and Table 3).
Stratified analysis showed: Mean age of Staphylococcus aureus po-
sitive cases was 25.2 ± 4.7 years compared to 25.9 ± 5.8 years in
Staphylococcus aureuscases (p-0.49) and among male patients 19.2%
had Staphylococcus aureuscases compared to 11.3% in female cases (p-
0.16); mean age of E. coli positive cases was 28.2 ± 6.1 years com-
pared to 25.5 ± 5.5 years in E. coli negative cases (p-0.02) and among
male patients 14.2% had E. coli positive cases compared to 15% in fe-
male cases (p-0.51); Mean age of Pseudomonas aeruginosa positive cases
was 25.6 ± 3.6 years compared to 25.8 ± 5.8 years in Pseudomonas
aeruginosanegative cases (p-0.82) and among male patients 7.5% had
Pseudomonas aeruginosa positive cases compared to 10% in female cases
(p-0.35) and mean age of Klebsiella pneumonae positive cases was
25.9 ± 4.6 years compared to 25.8 ± 5.8 years in Klebsiella pneu-
monae negative cases (p-0.93) and among male patients 14.2% had
Klebsiella pneumonae positive cases compared to 17.5% in female cases
(p-0.32).
4. Discussion
Febrile neutropenia is the development of fever, often with other
signs of infection, in a patient with neutropenia, an abnormally low
number of neutrophil granulocytes (a type of white blood cell) in the
blood. The term neutropenic sepsis is also applied, although it tends to
Table 1
Characteristics of patients.
Age
Mean ± SD 25.8 ± 5.7 years
Sex
Male 80 (40%)
Female 120 (60%)
Temperature
Low grade (102 F) 89 (44.5%)
High grade (> 102 F) 111 (55.5%)
Pathogens
Staphylococcus aureus 32 (16%)
E. coli 29 (14.5%)
Pseudomonas aeruginosa 17 (8.5%)
Klebsiella pneumonae 31 (15.5%)
Table 2
Stratified analysis of pathogens by age.
STAPHYLOCOCCUS AUREUS P-value
Positive Negative
Mean age 25.2 ± 4.7 25.9 ± 5.8 0.49
PSEUDOMONAS AERUGINOSA P-value
Positive Negative
Mean age 25.6 ± 3.6 25.8 ± 5.8 0.82
E. COLI P-value
Positive Negative
Mean age 28.2 ± 6.1 25.5 ± 5.5 0.02
KLEBSIELLA PNEUMONAE P-value
Positive Negative
Mean age 25.9 ± 4.6 25.8 ± 5.8 0.93
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be reserved for patients who are less well. Fever is actually caused by
infection in 50% of cases, and bloodstream infection (bacteria in the
bloodstream) may be present in as many as 20% of all patients with an
absolute neutrophil count under [10.12].
Febrile neutropenia can develop in any form of neutropenia, but is
most generally recognized as a complication of chemotherapy when it is
myelosuppressive (suppresses the bone marrow from producing blood
cells). Generally, patients with febrile neutropenia are treated with
empirical antibiotics until the neutrophil count has recovered and the
fever has abated; if the neutrophil count does not improve, treatment
may need to continue for two weeks or occasionally more [11].
Bacterial infections in neutropenic patients are a major cause of
morbidity and mortality [13,14]. Knowledge of the locally prevalent
pathogens and their susceptibility patterns is important before putting
these patients on empiric antimicrobial therapy. Thirty years ago most
of the infections in these patients were caused by aerobic Gram-nega-
tive bacilli. Over the last twenty years however, a shift in the bacterial
spectrum towards Gram-positive cocci has been reported in the West
[14–17].Although the exact cause of this shift is not known, long-
dwelling intravascular devices, fluoroquinolone prophylaxis and che-
motherapy-induced mucositis have been implicated [18,19]. This trend
however has not been prominent in the developing world [20].
Coagulase negative staphylococcus (CoNS) are the commonest or-
ganisms isolated in the Western countries followed by Staphylococcus
aureus. Other Gram-positive cocci like enterococci and viridans strep-
tococci are increasingly being reported as important causes of infection.
Among the Gram-negative bacteria, Escherichia coli, Pseudomonas aer-
uginosa and Klebsiella sp. are the common pathogens [21–23]. In a
study although Gram-negative bacilli (57%) were the predominant
isolates, statistically their isolation rate did not significantly differ from
Gram-positive isolates (0.5 > p > 0.1). Almost half (43%) of the pa-
tients were infected with Gram-positive cocci, CoNS being the com-
monest (26%). In 1998, Karamatet al [24] had reported a pre-
dominance of Gram-negative isolates from neutropenic patients in the
same setting. Among Gram-positive organisms, Staphylococcus aureus
was the commonest isolate in their study [13].A definite shift towards
Gram-positive microorganisms has been observed in our study with
CoNS as the predominant isolates.
In this study the frequency of staphylococcus aureus was 16%, e.
coli was 14.5%, Pseudomonas 8.5% and Klebsiella 15.5% in febrile
neutropenic patients. In a study was aiming to study trends in bacterial
spectrum reported that the most common organisms were: Escherichia
coli (23.1%), Staphylococcus epidermidis (13.9%), Pseudomonas aeru-
ginosa (12.5%) and Staphylococcus aureus (7.9%). In another study, it
was reported that gram-positive infections accounted for 49% (with
coagulase-negative staphylococci the most frequent); monomicrobial,
gram-negative infections accounted for 36% (with Escherichia coli the
most frequent); and 15% of infections were polymicrobial. The findings
of two study showed that organism varies in different population.
5. Conclusion
It was concluded from this study that the frequency of bloodstream
infection in patients of febrile neutropenia was Staphylococcus aureus
16%, E. coli was 14.5% Pseudomonas 8.5% and Klebsiella 15.5%.
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